Andrew Combs - 25 Mar 2025 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Signature
/s/ Krishna Vaddi, Attorney-in-Fact
Issuer symbol
PRLD
Transactions as of
25 Mar 2025
Net transactions value
+$69,250
Form type
4
Filing time
27 Mar 2025, 16:40:54 UTC
Previous filing
05 Feb 2025
Next filing
05 Feb 2026

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRLD Common Stock Purchase $69,250 +100,000 +26% $0.6925 480,123 25 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported total includes 2,500 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c).